A T cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.406. It has been cited 14 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.406
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: R01 AI157975
NIH
Grant: R01AI139092,from NIH
NIAID NIH HHS
Grant: R01 AI139092
National Institutes of Health
Grant: 7R01AI157975-02
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
National Institutes of Health
Grant: 5R01AI139092-04
Structure-based design of coronavirus subunit vaccines
Fields of Study
MeSH Terms
Keywords